If you would like to contact the Media Office, please email us at firstname.lastname@example.org or call us on +44 (0)20 7611 8866.
Emily Philippou - Media Officer
T +44 (0)20 7611 8726
Tim Morley - Senior Media Officer (Wellcome Collection)
T +44 (0)20 7611 8612
Holly Story - Assistant Media Officer (Wellcome Collection)
T +44 (0)20 7611 8248
Clare Ryan - Senior Media Officer
T +44 (0)20 7611 7262
Helen Jamison - Head of Media Relations
T +44 (0)20 7611 7329
Or contact us by post at: Gibbs Building, 215 Euston Road, London NW1 2BE, UK
For copies of the Wellcome Trust logo, please email email@example.com.
Wellcome Trust announces 2013/14 annual results
Wellcome Trust and Wellcome Trust Finance plc. (a wholly owned subsidiary of Wellcome Trust) announce that they have each published their Annual Report and Financial Statements for the year to 30 September 2014 today.
17 December 2014
First co-production feature film from the Wellcome Trust: 'Electricity'
'Electricity', the Wellcome Trust’s first co-production feature film, is released in select cinemas nationally from 12 December, by Soda Pictures. Starring Agyness Deyn as a young woman with temporal lobe epilepsy, the film takes the viewer on a hallucinatory journey as she searches for her lost brother.
10 December 2014
'Voices in the dark': Mosaic's first audio feature
Mosaic, the online publication from the Wellcome Trust, today releases its first audio-only feature: 'Voices in the dark', an exploration the phenomenon of voice hearing, its historical and social contexts, and its future treatments.
09 December 2014
Wellcome Collection unveils immersive digital story 'Mindcraft: A century of madness, murder and mental healing'
Wellcome Collection’s first digital story, ‘Mindcraft: A century of madness, murder and mental healing’, publishes online today.
4 December 2014
Pharmaceutical companies join funders and charities to commit to action on childhood HIV
A group of research-based pharmaceutical companies – AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck & Co. and ViiV Healthcare – have come together as the HIV Medicines Research Industry Forum to support the development of new, high-priority paediatric treatments for HIV infection by 2017.
2 December 2014